Danone (OTCMKTS:DANOY) Receives Consensus Rating of “Hold” from Analysts

Danone (OTCMKTS:DANOY – Get Free Report) has earned a consensus rating of “Hold” from the seven brokerages that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company.

A number of analysts have weighed in on DANOY shares. Jefferies Financial Group cut shares of Danone from a “buy” rating to an “underperform” rating in a research note on Tuesday. Morgan Stanley reiterated an “overweight” rating on shares of Danone in a research note on Monday, June 29th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Danone in a research report on Friday, July 3rd. Finally, Santander raised Danone to an “outperform” rating in a report on Wednesday, June 10th.

Get Danone alerts:

Check Out Our Latest Analysis on Danone

Danone Price Performance

DANOY stock opened at $15.96 on Wednesday. The company has a current ratio of 0.90, a quick ratio of 0.75 and a debt-to-equity ratio of 0.58. The company has a 50 day simple moving average of $15.60 and a 200 day simple moving average of $16.02. Danone has a 1 year low of $14.19 and a 1 year high of $18.63.

About Danone

(Get Free Report)

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.

Featured Stories

• Five stocks we like better than Danone
• AMD and Cerbras Create A New Blueprint For Hardware
• Intel Earnings Reveal Whether the Chip Selloff Created a Buy
• CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
• Plugging In: How Kinder Morgan Powers Up Profits

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.